Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin

Journal of Virology

Volumn 79, Issue 9, 2005, Pages 5863-5869

  Andrei, Graciela ^a   Balzarini, Jan ^a   Fiten, Pierre ^a   De Clercq, Erik ^a   Opdenakker, Ghislain ^a   Snoeck, Robert ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ALANINE; ARGININE; CYTOSINE; GLYCINE; GUANINE; SERINE; THREONINE; THYMIDINE KINASE; TRYPTOPHAN; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; ARTIFICIAL SELECTION; CLONE; FRAMESHIFT MUTATION; GENOTYPE; HERPES SIMPLEX VIRUS 1; NONHUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; STOP CODON; VIRUS VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; BROMODEOXYURIDINE; CERCOPITHECUS AETHIOPS; CODON, TERMINATOR; DRUG RESISTANCE, VIRAL; FRAMESHIFT MUTATION; MODELS, MOLECULAR; PHENOTYPE; SELECTION (GENETICS); SIMPLEXVIRUS; THYMIDINE KINASE; VERO CELLS;

HERPES; HUMAN HERPESVIRUS 1;

EID: 17444409992     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.9.5863-5869.2005     Document Type: Article

References (47)

1. Andrei, G., R. Snoeck, E. De Clercq, R. Esnouf, P. Fiten, and G. Opdenakker. 2000. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. J. Gen. Virol. 81:639-648.
2. Bacon, T. H., M. J. Levin, J. J. Leary, R. T. Sarisky, and D. Sutton. 2003. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin. Microbiol. Rev. 16:114-128.
3. Chakrabarti, S, D. Pillay, D. Ratcliffe, P. A. Cane, K. E. Collinghan, and D. W. Milligan. 2000. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance. J. Infect. Dis. 181:2055-2058.
4. Champness, J. N., M. S. Bennett, F. Wien, R. Visse, W. C. Summers, P. Herdewijn, E. de Clerq, T. Ostrowski, R. L. Jarvest, and M. R. Sanderson. 1998. Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands. Proteins 32:350-361.
5. Chen, J., J. B. Anderson, C. DeWeese-Scott, N. D. Fedorova, L. Y. Geer, S. He, D. I. Hurwitz, J. D. Jackson, A. R. Jacobs, C. J. Lanczycki, C. A. Liebert, C. Liu, T. Madej, A. Marchler-Bauer, G. H. Marchler, R. Mazumder, A. N. Nikolskaya, B. S. Rao, A. R. Panchenko, B. A. Shoemaker, V. Simonyan, J. S. Song, P. A. Thiessen, S. Vasudevan, Y. Wang, R. A. Yamashita, J. J. Yin, and S. H. Bryant. 2003. MMDB: Entrez's 3D-structure database. Nucleic Acids Res. 31:474-477.
6. Chen, Y., C. Scieux, V. Garrait, G. Socié, V. Rocha, J. M. Molina, D. Thouvenot, F. Morfin, I. Hocqueloux, L. Garderet, H. Esperou, F. Selimi, A. Dervergie, G. Leleu, M. Aymard, F. Morinet, E. Gluckman, and P. Ribaud. 2000. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin. Infect. Dis. 31:927-935.
7. Chibo, D., J. Druce, J. Sasadeusz, and C. Birch. 2004. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antivir. Res. 61:83-91.
8. Christophers, J., J. Clayton, J. Craske, R. Ward, P. Collins, M. Trowbridge, and G. Darby. 1998. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob. Agents Chemother. 42:868-872.
9. Coen, D. M., P. A. Schaffer, P. A. Furman, P. M. Keller, and M. H. St. Clair. 1982. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1. Am. J. Med. 73:351-360.
10. Coen, D. M., M. Kosz-Vnenchak, J. G. Jacobson, D. A. Leib, C. L. Bogard, P. A. Schaffer, K. L. Tyler, and D. M. Knipe. 1989. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA 86:4736-4740.
11. Coen, D. M. 1994. Acyclovir-resistant, pathogenic herpesviruses. Trends Microbiol. 2:481-485.
12. Collins, P., and G. Darby. 1991. Laboratory studies of herpes simplex virus strains resistant to acyclovir. Rev. Med. Virol. 1:19-28.
13. Collins, P., B. A. Larder, N. M. Oliver, S. Kemp, I. W., Smith, and G. Darby. 1989. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J. Gen. Virol. 70:375-382.
14. Chrisp, C. E., J. C. Sunstrum, D. R. Averill, Jr., M. Levine, and J. C. Glorioso. 1989. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence. Lab. Investig. 60:822-830.
15. Darby, G., H. J. Field, and S. A. Salisbury. 1981. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature 289:81-83.
16. Darby, G., M. J. Churcher, and B. A. Larder. 1984. Cooperative effects between two acyclovir resistance loci in herpes simplex virus. J. Virol. 50: 838-846.
17. Darby, G., B. A. Larder, and M. M. Inglis. 1986. Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. J. Gen. Virol. 67:753-758.
18. Degrève, B., E. De Clercq, and J. Balzarini. 1999. Bystander effect of purine nucleoside analogues in HSV-1 tk gene therapy is superior to that of pyrimidine nucleoside analogues. Gene Ther. 6:162-170.
19. Docherty, J. J., A. T. Dobson, J. J. Trimble, and B. A. Jennings. 1991. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(bromovinyl)-2′-deoxyuridine. Intervirology 32:308-315.
20. Efstathiou, S., S. Kemp, G. Darby, and A. C. Minson. 1989. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70:869-879.
21. Evans, J. S., K. P. Lock, B. A. Levine, J. N. Champness, M. R. Sanderson, W. C. Summers, P. J. McLeish, and A. Buchan. 1998. Herpesviral thymidine kinases: laxity and resistance by design. J. Gen. Virol. 79:2083-2092.
22. Field, H. J., and G. Darby. 1980. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob. Agents Chemother. 17:209-216.
23. Field, H. J., and J. Neden. 1982. Isolation of bromovinyldeoxyuridine- resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir. Antiviral Res. 2:243-254.
24. Field, H. J., and D. M. Coen. 1986. Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. J. Virol. 60:286-288.
25. Fyfe, J. A. 1982. Differential phosphorylation of (E)-5-(2-bromovinyl)- 2′-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus. Mol. Pharmacol. 21:432-437.
26. Gaudreau, A., E. Hill, H. H. Balfour, Jr., A. Erice, and G. Boivin. 1998. Phenotypic and genotyic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J. Infect. Dis. 178:297-303.
27. Harris, W., P. Collins, F. J. Fenton, W. Snowden, M. Sowa, and G. Darby. 2003. Phenotypic and genotypic characterization of clinical isolates of herpes simplex virus resistant to acyclovir. J. Gen. Virol. 84:1393-1401.
28. Hill, E. L., G. A. Hunter, and M. N. Ellis. 1991. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 35:2322-2328.
29. Hwang, C. B. C., K. L. Ruffner, and D. M. Coen. 1992. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance. J. Virol. 66:1774-1776.
30. Hwang, C. B. C., and H. J. H. Chen. 1995. An altered spectrum of herpes simplex virus mutations mediated by an antimutator DNA polymerase. Gene 152:191-193.
31. Jacobson, J. G., K. L., Ruffner, M. Kosz-Vnenchak, C. B. C. Hwang, K. K. Wobe, D. M. Knipe, and D. M. Coen. 1993. Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J. Virol. 67:6903-6908.
32. Kussmann-Gerber, S., O. Kuonen, G. Folkers, B. D. Pilger, and L. Scapozza. 1998. Drug resistance of herpes simplex virus type 1-structural considerations at the molecular level of the thymidine kinase. Eur. J. Biochem. 255:472-481.
33. Larder, B. A., Y. C. Cheng, and G. Darby. 1983. Characterization of abnormal thymidine kinases induced by drug-resistant strains of herpes simplex virus type 1. J. Gen. Virol. 64:523-532.
34. Leary, J. J., R. Wittrock, R. T. Sarisky, A. Weinberg, and M. J. Levin. 2002. Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines. Antimicrob. Agents Chemother. 46:762-768.
35. Morfin, F., G. Souillet, K. Bilger, T. Ooka, M. Aymard, and D. Thouvenot. 2000. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J. Infect. Dis. 182:290-293.
36. Nugier, F., J. N. Colin, M. Aymard, and M. Langlois. 1992. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J. Med. Virol. 36:1-12.
37. Pelosi, E., G. B. Mulamba, and D. M. Coen. 1998. Penciclovir and pathogenesis phenotypes of drug-resistant herpes simplex virus mutants. Antivir. Res. 37:17-28.
38. Pelosi, E., F. Rozenberg, D. M. Coen, and K. L. Tyler. 1998. A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice. Virology 252:364-372.
39. Pilger, B. D., R. Perozzo, F. Alber, C. Wurth, G. Folkers, L. Scapozza. 1999. Substrate diversity of herpes simplex virus thymidine kinase. Impact of the kinematics of the enzyme. J. Biol. Chem. 274:31967-31973.
40. Pottage, J. C., Jr., and H. A. Kessler. 1995. Herpes simplex virus resistance to acyclovir: clinical relevance. Infect. Agents Dis. 4:115-124.
41. 40a. Reed, J. H., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
42. Sacks, S. L., R. J. Wanklin, D. E. Reece, K. A. Hicks, K. L. Tyler, and D. M. Coen. 1989. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? Ann. Intern. Med. 111:893-899.
43. Sarisky, R. T., M. R. Quail, P. E. Clark, T. T. Nguyen, W. S. Halsey, R. J. Wittrock, J. O'Leary Bartus, M. M. Van Horn, G. M. Sathe, S. Van Horn, M. D. Kelly, T. H. Bacon, J. J. Leary. 2001. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir. J. Virol. 75:1761-1769.
44. Sasadeusz, J. J., F. Tufaro, S. Safrin, K. Schubert, M. M. Hubinette, P. K. Cheung, and S. L. Sacks. 1997. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J. Virol. 71:3872-3878.
45. Suzutani, T., K. Ishioka, E. De Clercq, K. Ishibashi, H. Kaneko, T. Kira, K.-I. Hashimoto, M. Ogasawara, K. Ohtani, N. Wakamiya, and M. Saijo. 2004. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir and penciclovir. Antimicrob. Agents Chemother. 47:1707-1713.
46. Tenser, R. B. 1983. Intracerebral inoculation of newborn and adult mice with thymidine kinase-deficient mutants of herpes simplex virus type 1. J. Infect. Dis. 147:956.
47. Wilber, B. A., and J. J. Docherty. 1994. Analysis of the thymidine kinase of herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2′-deoxyuridine. J. Gen. Virol. 75:1743-1747.